Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
Free Radical Biology & Medicine|March 27, 2013
Nox4 and diabetic nephropathy: with a friend like this, who needs enemies?Yves Gorin, Karen BlockClinical Science (London, England : 1979)|June 18, 2013
Nox as a target for diabetic complicationsYves Gorin, Karen BlockNature Reviews. Cancer|August 25, 2012
Aiding and abetting roles of NOX oxidases in cellular transformationKaren Block, Yves GorinProceedings of the National Academy of Sciences of the United States of America|August 27, 2009
Subcellular localization of Nox4 and regulation in diabetesKaren Block, Yves Gorin, Hanna E AbboudAmerican Journal of Physiology. Cell Physiology|September 24, 2011
IGF-I increases the expression of fibronectin by Nox4-dependent Akt phosphorylation in renal tubular epithelial cellsDavid D New, Karen Block, Basant Bhandhari, et al.The Journal of Biological Chemistry|June 19, 2008
Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expressionKaren Block, Assaad Eid, Kathy K Griendling, et al.The Journal of Biological Chemistry|September 2, 2005
Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidneyYves Gorin, Karen Block, James Hernandez, et al.Antioxidants & Redox Signaling|September 22, 2006
Arachidonic acid-dependent activation of a p22(phox)-based NAD(P)H oxidase mediates angiotensin II-induced mesangial cell protein synthesis and fibronectin expression via Akt/PKBKaren Block, Jill M Ricono, Duck-Yoon Lee, et al.Diabetes|February 12, 2009
Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidasesAssaad A Eid, Yves Gorin, Bridget M Fagg, et al.Kidney International|March 30, 2013
Nox4 as a potential therapeutic target for treatment of uremic toxicity associated to chronic kidney diseaseYves GorinPageof 12